Covid-19专题文献--西安交通大学图书馆

《LANCET》 (共116篇，更新至2022年3月16日)

Title：Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study
Authors：Yen, H L; Sit, THC; Brackman, C J; Chuk, SSY; Gu, H; Tam, KWS; etc.
Date Display: 2022-03-12

Title：Prioritise research on vaccines for pregnant and breastfeeding women
Authors：Manca, T; Baylis, F; Munoz, F M; Top, K A
Date Display: 2022-03-05

Title：Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Authors：Feikin, D R; Higdon, M M; Abu-Raddad, L J; Andrews, N; Araos, R; etc.
Date Display: 2022-03-05

Title：Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021
Authors：Flor, L S; Friedman, J; Spencer, C N; Cagney, J; Arrieta, A; Herbert, M E; etc.
Date Display: 2022-03-02

Title：Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Authors：Nordstr?m, P; Ballin, M; Nordstr?m, A
Date Display: 2022-02-26

Title：Diagnostics for COVID-19: moving from pandemic response to control
Authors：Peeling, R W; Heymann, D L; Teo, Y Y; Garcia, P J
Date Display: 2022-02-19

Title：Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Authors：Costa, Clemens SA; Weckx, L; Clemens, R; Almeida, Mendes AV; etc.
Date Display: 2022-02-05

Title：Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Authors：Bravo, L; Smolenov, I; Han, H H; Li, P; Hosain, R; Rockhold, F; etc.
Date Display: 2022-01-29

Title：Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability
Authors：Moon, S; Armstrong, J; Hutler, B; Upshur, R; Katz, R; Atuire, C; etc.
Date Display: 2022-01-29

Title：Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Authors：Wolter, N; Jassat, W; Walaza, S; Welch, R; Moultrie, H; Groome, M; etc.
Date Display: 2022-01-29

Title：Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; Sheppard, M; etc.
Date Display: 2022-01-08

Title：Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2022-01-01

Title：Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
Authors：Katikireddi, S V; Cerqueira-Silva, T; Vasileiou, E; Robertson, C; Amele, S; etc.
Date Display: 2022-01-01

Title：Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Authors：Ramacciotti, E; Barile, Agati L; Calderaro, D; Aguiar, VCR; Spyropoulos, A C; etc.
Date Display: 2022-01-01

Title：Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; Clout, M; etc.
Date Display: 2021-12-18

Title：Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D; etc.
Date Display: 2021-12-18

Title：Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Authors：Ramacciotti, E; Barile, Agati L; Calderaro, D; Aguiar, VCR; Spyropoulos, A C; etc.
Date Display: 2021-12-15

Title：Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11

Title：Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11

Title：Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11

Title：Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11

Title：Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability
Authors：Moon, S; Armstrong, J; Hutler, B; Upshur, R; Katz, R; Atuire, C; Bhan, A; etc.
Date Display: 2021-12-10

Title：Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-12-06

Title：Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; Kohane, I S; etc.
Date Display: 2021-12-04

Title：How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic
Authors：Singh, S; McNab, C; Olson, R M; Bristol, N; Nolan, C; Bergstr?m, E; etc.
Date Display: 2021-12-04

Title：How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic
Authors：Singh, S; McNab, C; Olson, R M; Bristol, N; Nolan, C; Bergstr?m, E; etc.
Date Display: 2021-12-04

Title：Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; etc.
Date Display: 2021-12-04

Title：Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D;etc.
Date Display: 2021-12-02

Title：Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2021-11-17

Title：A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries
Authors：Bhutta, Z A; Salam, R A; Gomber, A; Lewis-Watts, L; Narang, T; etc.
Date Display: 2021-11-13

Title：Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; etc.
Date Display: 2021-11-11

Title：Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; etc.
Date Display: 2021-11-03

Title：Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019
Authors：
Date Display: 2021-10-30

Title：Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Authors：Sonabend, R; Whittles, L K; Imai, N; Perez-Guzman, P N; Knock, E S; etc.
Date Display: 2021-10-27

Title：The evolution of the Italian National Health Service
Authors：Ricciardi, W; Tarricone, R
Date Display: 2021-10-22

Title：Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Authors：Tartof, S Y; Slezak, J M; Fischer, H; Hong, V; Ackerson, B K; Ranasinghe, O N; etc.
Date Display: 2021-10-16

Title：Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Authors：
Date Display: 2021-10-08

Title：Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry
Authors：Barbaro, R P; MacLaren, G; Boonstra, P S; Combes, A; Agerstrand, C; etc.
Date Display: 2021-10-02

Title：Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Authors：Perry, R J; Tamborska, A; Singh, B; Craven, B; Marigold, R; etc.
Date Display: 2021-09-25

Title：Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
Authors：
Date Display: 2021-09-22

Title：Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial
Authors：Young, B C; Eyre, D W; Kendrick, S; White, C; Smith, S; Beveridge, G; etc.
Date Display: 2021-09-14

Title：Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Authors：Lindenfeld, J; Zile, M R; Desai, A S; Bhatt, K; Ducharme, A; etc.
Date Display: 2021-09-11

Title：Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Authors：Flaxman, A; Marchevsky, N G; Jenkin, D; Aboagye, J; Aley, P K; etc.
Date Display: 2021-09-11

Title：Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Authors：Liu, X; Shaw, R H; Stuart, ASV; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-09-04

Title：Mental illness and suicide among physicians
Authors：Harvey, S B; Epstein, R M; Glozier, N; Petrie, K; Strudwick, J; etc.
Date Display: 2021-09-04

Title：Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Authors：Yu, L M; Bafadhel, M; Dorward, J; Hayward, G; Saville, B R; etc.
Date Display: 2021-09-04

Title：1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Authors：Huang, L; Yao, Q; Gu, X; Wang, Q; Ren, L; Wang, Y; Hu, P; etc.
Date Display: 2021-08-28

Title：Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
Authors：Katsoularis, I; Fonseca-Rodr¨ªguez, O; Farrington, P; Lindmark, K; etc.
Date Display: 2021-08-14

Title：Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study
Authors：Hillis, S D; Unwin, HJT; Chen, Y; Cluver, L; Sherr, L; Goldman, P S; etc.
Date Display: 2021-07-20

Title：Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Authors：Drake, T M; Riad, A M; Fairfield, C J; Egan, C; Knight, S R; Pius, R; Hardwick, H E; etc.
Date Display: 2021-07-17

Title：Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Authors：Tanriover, M D; Doğanay, H L; Akova, M; Güner, H R; Azap, A; Akhan, S; etc.
Date Display: 2021-07-17

Title：Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study
Authors：Causey, K; Fullman, N; Sorensen, RJD; Galles, N C; Zheng, P; Aravkin, A; etc.
Date Display: 2021-07-14

Title：Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis
Authors：Palmer, K R; Tanner, M; Davies-Tuck, M; Rindt, A; Papacostas, K; etc.
Date Display: 2021-07-03

Title：Acute respiratory distress syndrome
Authors：Meyer, N J; Gattinoni, L; Calfee, C S
Date Display: 2021-07-01

Title：Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Authors：Borobia, A M; Carcas, A J; P¨¦rez-Olmeda, M; Casta?o, L; Bertran, M J; etc.
Date Display: 2021-06-25

Title：Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Authors：Lopes, R D; de Barros, E Silva PGM; Furtado, RHM; Macedo, AVS; etc.
Date Display: 2021-06-12

Title：Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study
Authors：
Date Display: 2021-05-22

Title：What is the right level of spending needed for health and care in the UK?
Authors：Charlesworth, A; Anderson, M; Donaldson, C; Johnson, P; etc.
Date Display: 2021-05-22

Title：Securing a sustainable and fit-for-purpose UK health and care workforce
Authors：Anderson, M; O'Neill, C; Macleod, Clark J; Street, A; Woods, M; etc.
Date Display: 2021-05-22

Title：The changing health needs of the UK population
Authors：McKee, M; Dunnell, K; Anderson, M; Brayne, C; Charlesworth, A; etc.
Date Display: 2021-05-22

Title：Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Authors：Haas, E J; Angulo, F J; McLaughlin, J M; Anis, E; Singer, S R; Khan, F; etc.
Date Display: 2021-05-15

Title：Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Authors：
Date Display: 2021-05-14

Title：Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
Authors：Mathur, R; Rentsch, C T; Morton, C E; Hulme, W J; Schultze, A; MacKenna, B; etc.
Date Display: 2021-05-08

Title：Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2021-05-01

Title：Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2021-05-01

Title：Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
Authors：Mathur, R; Rentsch, C T; Morton, C E; Hulme, W J; Schultze, A; etc.
Date Display: 2021-04-30

Title：COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Authors：Hall, V J; Foulkes, S; Saei, A; Andrews, N; Oguti, B; Charlett, A; etc.
Date Display: 2021-04-23

Title：Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Authors：Emary, KRW; Golubchik, T; Aley, P K; Ariani, C V; Angus, B; Bibi, S; etc.
Date Display: 2021-04-10

Title：New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK
Authors：Williams, R; Alessi, C; Alexander, G; Allison, M; Aspinall, R; Batterham, R L; etc.
Date Display: 2021-03-10

Title：Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development
Authors：Lurie, N; Keusch, G T; Dzau, V J
Date Display: 2021-03-09

Title：Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Authors：
Date Display: 2021-03-04

Title：Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Authors：Richmond, P; Hatchuel, L; Dong, M; Ma, B; Hu, B; Smolenov, I; etc.
Date Display: 2021-02-20

Title：Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2021-02-13

Title：Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Authors：Wouters, O J; Shadlen, K C; Salcher-Konrad, M; Pollard, A J; Larson, H J; etc.
Date Display: 2021-02-12

Title：6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Authors：Huang, C; Huang, L; Wang, Y; Li, X; Ren, L; Gu, X; Kang, L; Guo, L; Liu, M; etc.
Date Display: 2021-01-16

Title：Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Authors：Voysey, M; Clemens, SAC; Madhi, S A; Weckx, L Y; Folegatti, P M; Aley, P K; etc.
Date Display: 2020-12-08

Title：Centring adolescent girls and young women in the HIV and COVID-19 responses
Authors：Goga, A; Bekker, L G; Van de Perre, P; El-Sadr, W; Ahmed, K; etc.
Date Display: 2020-11-27

Title：Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Authors：Ramasamy, M N; Minassian, A M; Ewer, K J; Flaxman, A L; etc.
Date Display: 2020-11-18

Title：Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
Authors：Barbaro, R P; MacLaren, G; Boonstra, P S; Iwashyna, T J; etc.
Date Display: 2020-10-10

Title：Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2020-10-05

Title：Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Authors：Anand, S; Montez-Rath, M; Han, J; Bozeman, J; etc.
Date Display: 2020-09-25

Title：Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Authors：Furtado, RHM; Berwanger, O; Fonseca, H A; Corr¨ºa, T D, etc.
Date Display: 2020-09-04

Title：Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Authors：Logunov, D Y; Dolzhikova, I V; Zubkova, O V; etc.
Date Display: 2020-09-03

Title：Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Authors：Zhu, F C; Guan, X H; Li, Y H; Huang, J Y; etc.
Date Display: 2020-07-20

Title：Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Authors：Folegatti, P M; Ewer, K J; Aley, P K; Angus, B; etc.
Date Display: 2020-07-20

Title：Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
Authors：Bradley, B T; Maioli, H; Johnston, R; Chaudhry, I; etc.
Date Display: 2020-07-16

Title：Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Authors：Poll¨¢n, M; P¨¦rez-G¨®mez, B; Pastor-Barriuso, R; Oteo, J; etc.
Date Display: 2020-07-03

Title：Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Authors：Stringhini, S; Wisniak, A; Piumatti, G; Azman, A S; etc.
Date Display: 2020-06-11

Title：Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Authors：Chu, D K; Akl, E A; Duda, S; Solo, K; Yaacoub, S; Sch¨¹nemann, H J
Date Display: 2020-06-01

Title：Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon
Authors：Kaplan, H S; Trumble, B C; Stieglitz, J; Mamany, R M; etc.
Date Display: 2020-05-30

Title：Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Authors：de Abajo, F J; Rodr¨ªguez-Mart¨ªn, S; Lerma, V; Mej¨ªa-Abril, G; etc.
Date Display: 2020-05-30

Title：Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
Authors：Banerjee, A; Pasea, L; Harris, S; Gonzalez-Izquierdo, A; etc.
Date Display: 2020-05-30

Title：Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Authors：Hung, I F; Lung, K C; Tso, E Y; Liu, R; Chung, T W; Chu, M Y; etc.
Date Display: 2020-05-30

Title：Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Authors：
Date Display: 2020-05-29

Title：COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Authors：Lee, LYW; Cazier, J B; Starkey, T; Turnbull, C D; etc.
Date Display: 2020-05-28

Title：Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Authors：Kuderer, N M; Choueiri, T K; Shah, D P; Shyr, Y;etc.
Date Display: 2020-05-28

Title：COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
Authors：Phelan, A L
Date Display: 2020-05-23

Title：Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Authors：Mehra, M R; Desai, S S; Ruschitzka, F; Patel, A N
Date Display: 2020-05-22

Title：Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Authors：Zhu, F C; Li, Y H; Guan, X H; Hou, L H; Wang, W J; etc.
Date Display: 2020-05-22

Title：Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Authors：Cummings, M J; Baldwin, M R; Abrams, D; Jacobson, S D; etc.
Date Display: 2020-05-19

Title：Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Authors：Wang, Y; Zhang, D; "Du G"; "Du R"; Zhao, J; Jin, Y; Fu, S;etc.
Date Display: 2020-05-16

Title：An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Authors：Verdoni, L; Mazza, A; Gervasoni, A; Martelli, L;etc.
Date Display: 2020-05-13

Title：SARS-CoV-2 and viral sepsis: observations and hypotheses
Authors：Li, H; Liu, L; Zhang, D; Xu, J; Dai, H; Tang, N; Su, X; Cao, B
Date Display: 2020-05-09

Title：Society and the slow burn of inequality
Authors：Marmot, M
Date Display: 2020-05-02

Title：First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment
Authors：Leung, K; Wu, J T; Liu, D; Leung, G M
Date Display: 2020-04-25

Title：First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
Authors：Ghinai, I; McPherson, T D; Hunter, J C; Kirking, H L;etc.
Date Display: 2020-04-04

Title：Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Authors：Zhou, F; Yu, T; "Du R"; Fan, G; Liu, Y; Liu, Z; Xiang, J; etc.
Date Display: 2020-03-28

Title：Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
Authors：Pung, R; Chiew, C J; Young, B E; Chin, S; Chen, M I; Clapham, H E; etc.
Date Display: 2020-03-28

Title：Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries
Authors：Kandel, N; Chungong, S; Omaar, A; Xing, J
Date Display: 2020-03-28

Title：Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
Authors：Gilbert, M; Pullano, G; Pinotti, F; Valdano, E; Poletto, C; etc.
Date Display: 2020-03-14

Title：Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
Authors：Wu, J T; Leung, K; Leung, G M
Date Display: 2020-02-29

Title：Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Authors：Lu, R; Zhao, X; Li, J; Niu, P; Yang, B; Wu, H; Wang, W; etc.
Date Display: 2020-02-22

Title：Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Authors：Chen, N; Zhou, M; Dong, X; Qu, J; Gong, F; Han, Y; Qiu, Y; etc.
Date Display: 2020-02-15

Title：Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Authors：Huang, C; Wang, Y; Li, X; Ren, L; Zhao, J; Hu, Y; Zhang, L; etc.
Date Display: 2020-02-15

Title：A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Authors：Chan, J F; Yuan, S; Kok, K H; To, K K; Chu, H; Yang, J; Xing, F; Liu, J; etc.
Date Display: 2020-02-15

Title：Offline: 2019-nCoV outbreak-early lessons
Authors：Horton, R
Date Display: 2020-02-01